tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INAB Stock Latest News

IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating
RatingsIN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating
5d ago
INAB
IN8bio presents Phase I/II data from INB-200 trials
PremiumThe Fly
IN8bio presents Phase I/II data from INB-200 trials
7d ago
INAB
IN8bio Announces Structured $40 Million Private Placement Financing
PremiumCompany Announcements
IN8bio Announces Structured $40 Million Private Placement Financing
1M ago
8K
INAB
IN8bio prices 5.13M shares at $1.38 in private placement
PremiumThe Fly
IN8bio prices 5.13M shares at $1.38 in private placement
1M ago
INAB
IN8bio Presents Promising Clinical Trial Results
PremiumCompany Announcements
IN8bio Presents Promising Clinical Trial Results
2M ago
8K
INAB
IN8bio files $200M mixed securities shelf
PremiumThe FlyIN8bio files $200M mixed securities shelf
2M ago
INAB
IN8Bio Reports Improved Financials Amid Ongoing Challenges
Premium
Company Announcements
IN8Bio Reports Improved Financials Amid Ongoing Challenges
2M ago
INAB
IN8bio expands INB-100 Phase 1 trial with new clinical site
Premium
The Fly
IN8bio expands INB-100 Phase 1 trial with new clinical site
3M ago
INAB
IN8bio Unveils Promising Preclinical Data for INB-619
PremiumCompany Announcements
IN8bio Unveils Promising Preclinical Data for INB-619
3M ago
8K
INAB
IN8bio presents new preclinical data from INB-619
PremiumThe Fly
IN8bio presents new preclinical data from INB-619
3M ago
INAB
IN8bio price target adjusted to $4 from $60 at Mizuho
PremiumThe Fly
IN8bio price target adjusted to $4 from $60 at Mizuho
3M ago
INAB
Positive Outlook on IN8bio: Buy Rating Backed by Promising Pipeline Developments and Strategic Financial Adjustments
PremiumRatings
Positive Outlook on IN8bio: Buy Rating Backed by Promising Pipeline Developments and Strategic Financial Adjustments
5M ago
INAB
In8bio, Inc. Reports Improved Financial Performance
PremiumCompany AnnouncementsIn8bio, Inc. Reports Improved Financial Performance
5M ago
INAB
IN8bio reports Q2 EPS ($1.24), consensus ($1.80)
Premium
The Fly
IN8bio reports Q2 EPS ($1.24), consensus ($1.80)
6M ago
INAB
IN8bio Regains Nasdaq Compliance with Bid Price Rule
Premium
Company Announcements
IN8bio Regains Nasdaq Compliance with Bid Price Rule
7M ago
8K
INAB
IN8bio recognizes 4-years in remission for patient treated with INB-200
PremiumThe Fly
IN8bio recognizes 4-years in remission for patient treated with INB-200
7M ago
INAB
IN8bio Inc trading halted, news pending
PremiumThe Fly
IN8bio Inc trading halted, news pending
8M ago
INAB
IN8bio Announces 1-for-30 Reverse Stock Split
PremiumCompany Announcements
IN8bio Announces 1-for-30 Reverse Stock Split
8M ago
8K
INAB
IN8bio’s Promising Clinical Trial Results and Strategic Developments Justify Buy Rating
PremiumRatings
IN8bio’s Promising Clinical Trial Results and Strategic Developments Justify Buy Rating
8M ago
INAB
IN8bio Announces Positive Phase 1 Trial Results
PremiumCompany AnnouncementsIN8bio Announces Positive Phase 1 Trial Results
8M ago
8K
INAB
IN8bio presents Phase 1 data on INB-200 in newly diagnosed GBM
Premium
The Fly
IN8bio presents Phase 1 data on INB-200 in newly diagnosed GBM
8M ago
INAB
IN8bio’s Promising Preclinical Data and Strategic Partnerships Drive Buy Rating
Premium
Ratings
IN8bio’s Promising Preclinical Data and Strategic Partnerships Drive Buy Rating
8M ago
INAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >